Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-20

Clinical Trial Update: Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and efficacy of ranibizumab for diabetic macular edema with center involvement; results were completed and posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lucentis (ranibizumab)

Snippet

Sponsor: Novartis | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2011-01-20